Markets /GNNSF Genscript Biotech Corporation GNNSF Full chart Compare Add to watchlist Set alert Price alert · GNNSF Alert when the price is Price abovePrice below Price level Set alert All alert types 4.50 USD 0.00 (+0.00%) At close·Nov 6, 2026, 4:00 PM EST 4.50 Day range 4.50 1.30 52-week range 6.55 YTD +171.08%1 year +114.29% Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2025FY 2024FY 2023FY 2022 Revenue → Gross Profit: $554.02MGross Profit → Expenses: $554.02MRevenue → Cost of Revenue: $406.92MExpenses → Selling, General & Admin: $227.06MExpenses → Research & Development: $71.34MExpenses → Interest Expense: $17.32MExpenses → Other Expenses: $709.96MExpenses → Income Tax: $61.96MNet Loss → Expenses: $533.62MGross Profit$554.02MNet Loss$533.62MCost of Revenue$406.92MExpenses$1.09BSelling, General & Admin$227.06MResearch & Development$71.34MInterest Expense$17.32MOther Expenses$709.96MIncome Tax$61.96MRevenue$960.95M No annual statement lines GNNSF has no annual lines for this statement.
